Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 4:11 pm Sale | 2021-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR | RA Capital Management, L.P. | 37,867 3.900% | -20,401 (-35.01%) | Filing History |
| 2022-01-10 5:00 pm Purchase | 2021-12-29 | 13G | Pardes Biosciences, Inc. PRDS | RA Capital Management, L.P. | 4,431,901 7.100% | 4,431,901 (New Position) | Filing History |
| 2021-12-22 4:32 pm Purchase | 2021-12-15 | 13G | BELLUS Health Inc. BLU | RA Capital Management, L.P. | 10,230,274 9.900% | 10,230,274 (New Position) | Filing History |
| 2021-12-20 4:33 pm Purchase | 2021-12-09 | 13G | Relmada Therapeutics, Inc. RLMD | RA Capital Management, L.P. | 2,000,000 7.200% | 2,000,000 (New Position) | Filing History |
| 2021-11-19 4:30 pm Purchase | 2021-11-19 | 13G | IO Biotech, Inc. IOBT | RA Capital Management, L.P. | 1,857,755 6.400% | 1,857,755 (New Position) | Filing History |
| 2021-11-15 4:35 pm Sale | 2021-11-15 | 13G | Defiance Trillion Dollar Club Index ETF TRIL | RA Capital Management, L.P. | 0 0.000% | -5,290,481 (Position Closed) | Filing History |
| 2021-11-15 4:35 pm Sale | 2021-11-15 | 13G | Inozyme Pharma, Inc. INZY | RA Capital Management, L.P. | 0 0.000% | -2,003,653 (Position Closed) | Filing History |
| 2021-11-15 4:34 pm Purchase | 2021-11-03 | 13G | LianBio LIANY | RA Capital Management, L.P. | 7,655,015 7.300% | 7,655,015 (New Position) | Filing History |
| 2021-11-15 4:34 pm Sale | 2021-11-15 | 13G | Helix Acquisition Corp. HLXA | RA Capital Management, L.P. | 0 0.000% | -700,000 (Position Closed) | Filing History |
| 2021-11-15 4:33 pm Sale | 2021-11-15 | 13G | Curis, Inc. CRIS | RA Capital Management, L.P. | 0 0.000% | -385,390 (Position Closed) | Filing History |
| 2021-11-15 4:33 pm Sale | 2021-11-15 | 13G | Aerpio Pharmaceuticals, Inc. ARPO | RA Capital Management, L.P. | 0 0.000% | -165,749 (Position Closed) | Filing History |
| 2021-11-15 4:32 pm Sale | 2021-11-15 | 13G | ARYA Sciences Acquisition Corp IV ARYD | RA Capital Management, L.P. | 0 0.000% | -1,000,000 (Position Closed) | Filing History |
| 2021-11-15 4:31 pm Sale | 2021-11-15 | 13G | Ardelyx, Inc. ARDX | RA Capital Management, L.P. | 0 0.000% | -24,652,344 (Position Closed) | Filing History |
| 2021-11-12 4:30 pm Purchase | 2009-02-28 | 13D | Wave Life Sciences Ltd. WVE | RA Capital Management, L.P. | 7,828,457 13.300% | 5,250 (+0.07%) | Filing History |
| 2021-11-05 4:34 pm Purchase | 2021-10-22 | 13G | Xilio Therapeutics, Inc. XLO | RA Capital Management, L.P. | 1,532,767 5.700% | 1,532,767 (New Position) | Filing History |
| 2021-10-28 4:32 pm Purchase | 2009-02-28 | 13D | Forma Therapeutics Holdings, Inc. FMTX | RA Capital Management, L.P. | 9,029,184 19.050% | 17,533 (+0.19%) | Filing History |
| 2021-10-28 4:23 pm Purchase | 2009-02-28 | 13D | KALA BIO, Inc. KALA | RA Capital Management, L.P. | 438,461 16.850% | 3,477 (+0.80%) | Filing History |
| 2021-10-25 4:35 pm Purchase | 2021-10-13 | 13G | Otonomy, Inc. OTIC | RA Capital Management, L.P. | 3,092,294 5.500% | 3,092,294 (New Position) | Filing History |
| 2021-10-25 4:34 pm Purchase | 2021-10-13 | 13G | Pyxis Oncology, Inc. PYXS | RA Capital Management, L.P. | 1,914,934 5.800% | 1,914,934 (New Position) | Filing History |
| 2021-10-01 4:30 pm Purchase | 2021-09-23 | 13G | Synlogic, Inc. SYBX | RA Capital Management, L.P. | 444,444 9.900% | 444,444 (New Position) | Filing History |